245 related articles for article (PubMed ID: 11831855)
1. Mapping the active site of endothelin-converting enzyme-1 through subsite specificity and mutagenesis studies: a comparison with neprilysin.
Johnson GD; Swenson HR; Ramage R; Ahn K
Arch Biochem Biophys; 2002 Feb; 398(2):240-8. PubMed ID: 11831855
[TBL] [Abstract][Full Text] [Related]
2. Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin.
Johnson GD; Stevenson T; Ahn K
J Biol Chem; 1999 Feb; 274(7):4053-8. PubMed ID: 9933597
[TBL] [Abstract][Full Text] [Related]
3. Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1.
Johnson GD; Ahn K
Anal Biochem; 2000 Nov; 286(1):112-8. PubMed ID: 11038281
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal segment of endothelin-converting enzyme (ECE)-1b contains a di-leucine motif that can redirect neprilysin to an intracellular compartment in Madin-Darby canine kidney (MDCK) cells.
Cailler F; Zappulla JP; Boileau G; Crine P
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):119-26. PubMed ID: 10377252
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
Hoang MV; Sansom CE; Turner AJ
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
[TBL] [Abstract][Full Text] [Related]
6. Molecular modelling and site-directed mutagenesis of the active site of endothelin-converting enzyme.
Sansom CE; Hoang MV; Turner AJ
Protein Eng; 1998 Dec; 11(12):1235-41. PubMed ID: 9930673
[TBL] [Abstract][Full Text] [Related]
7. Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11.
Shimada K; Takahashi M; Turner AJ; Tanzawa K
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):863-7. PubMed ID: 8645169
[TBL] [Abstract][Full Text] [Related]
8. Processing of proendothelin-1 at the C-terminus of big endothelin-1 is essential for proteolysis by endothelin-converting enzyme-1 in vivo.
Kido T; Sawamura T; Hoshikawa H; D'Orléans-Juste P; Denault JB; Leduc R; Kimura J; Masaki T
Eur J Biochem; 1997 Mar; 244(2):520-6. PubMed ID: 9119020
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling of the active site of endothelin-converting enzyme.
Sansom CE; Hoang VM; Turner AJ
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S75-7. PubMed ID: 8587473
[TBL] [Abstract][Full Text] [Related]
10. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.
Ahn K; Herman SB; Fahnoe DC
Arch Biochem Biophys; 1998 Nov; 359(2):258-68. PubMed ID: 9808768
[TBL] [Abstract][Full Text] [Related]
11. Molecular pharmacology of endothelin converting enzymes.
Turner AJ; Murphy LJ
Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
[TBL] [Abstract][Full Text] [Related]
12. Secretion of endothelin converting enzyme-1a: the hydrophobic signal anchor domain alone is not sufficient to promote membrane localization.
Brooks SC; Fernandez L; Ergul A
Mol Cell Biochem; 2000 May; 208(1-2):45-51. PubMed ID: 10939627
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of potent, selective inhibitors of endothelin-converting enzyme.
Wallace EM; Moliterni JA; Moskal MA; Neubert AD; Marcopulos N; Stamford LB; Trapani AJ; Savage P; Chou M; Jeng AY
J Med Chem; 1998 Apr; 41(9):1513-23. PubMed ID: 9554884
[TBL] [Abstract][Full Text] [Related]
14. Physiological relevance of hydrolysis of atrial natriuretic peptide by endothelin-converting enzyme-1.
Nakayama K; Emoto N; Suzuki Y; Vignon-Zellweger N; Yagi K; Hirata K
Kobe J Med Sci; 2012 Jun; 58(1):E12-8. PubMed ID: 22972025
[TBL] [Abstract][Full Text] [Related]
15. Disulfide bonds in big ET-1 are essential for the specific cleavage at the Trp(21)-Val(22) bond by soluble endothelin converting enzyme-1 from baculovirus/insect cells.
Fahnoe DC; Johnson GD; Herman SB; Ahn K
Arch Biochem Biophys; 2000 Jan; 373(2):385-93. PubMed ID: 10620363
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines.
Usmani BA; Harden B; Maitland NJ; Turner AJ
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():314S-317S. PubMed ID: 12193112
[TBL] [Abstract][Full Text] [Related]
17. Evidence by site-directed mutagenesis that arginine 203 of thermolysin and arginine 717 of neprilysin (neutral endopeptidase) play equivalent critical roles in substrate hydrolysis and inhibitor binding.
Marie-Claire C; Ruffet E; Antonczak S; Beaumont A; O'Donohue M; Roques BP; Fournié-Zaluski MC
Biochemistry; 1997 Nov; 36(45):13938-45. PubMed ID: 9374873
[TBL] [Abstract][Full Text] [Related]
18. Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2.
Gagnidze K; Sachchidanand ; Rozenfeld R; Mezei M; Zhou MM; Devi LA
J Med Chem; 2008 Jun; 51(12):3378-87. PubMed ID: 18507370
[TBL] [Abstract][Full Text] [Related]
19. Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin.
Hoang MV; Turner AJ
Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):23-6. PubMed ID: 9355729
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin-Darby canine kidney cells.
Azarani A; Boileau G; Crine P
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):439-48. PubMed ID: 9657986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
